Aerotel Medical System Form an Alliance with Italian Leading Telemedicine Services Provider Telbios

TelbiosTelbios, the leading telemedicine services provider in Italy, has signed an exclusivity agreement with Aerotel Medical System, world leader in manufacturing of medical devices and software platforms for telemedicine and Home Care services, for exclusive marketing and distribution of Aerotel innovative products in the Italian market.

AerotelThe agreement with Aerotel expands the range of telemedicine and home care services offered by Telbios, which includes Tele-assistance, Tele-cardiology, and Tele-radiology services. Health organizations such as hospitals, private and public healthcare institutions can now offer their patients a simple and efficient means to monitor the state of their health.

"The agreement with Aerotel is important since it gives us access to devices and technologies that are state of the art and that complete Telbios’s range of services offered," says Leopold Genovesi, CEO of Telbios.

Aerotel's devices such as EKG machines allow the patients to self measure the cardiologic parameters and send them, in short time, via telephone or GSM mobile phone handset, from any location to the call center. The transmitted information can be instantly interpreted by the team of cardiologists of San Raffaele Scientific Institute in Milan working within Telbios Telemedicine Service Center on a 24 hours call basis and immediately sent to the attending GP of the patient.

"Thanks to this technology the chronically ill patients can now avail of those technologies and are offered the possibility to be monitored without leaving the comfort of their home or while travelling and still follow a tight treatment protocol that results in the benefit of their quality of life," conclude Genovesi.

"Telemedicine is a growing market all over the globe and in Italy we can also see a very positive growth," says David Rubin, President & CEO of Aerotel Medical Systems."Having Telbios as a business partner will allow us both to develop dedicated solutions to the growing Italian market."

Monitoring the chronically ill patients can be considered as an emergency on a national level: in Italy there are over 2.5 million diabetic patients, over 4 million patients suffering for respiratory dysfunction, one million of patients suffering form chronic heart failure and the number of patients under anticoagulation treatment exceeds one million. Patients with two or more chronic diseases are the 19.4% of the population.

Telemedicine is the most suitable remote follow up method for the cited pathologies. Telemedicine reduces the unnecessary hospitalizations and reduces waiting lists for medical treatment with a significant saving factor on economical resources.

TELBIOS S.p.A.
Ufficio Stampa
Danilo Magliano
Tel .: +39 02 26433759
Mobile: +39 3357 563583
Web: www.telbios.it
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.

Aerotel
Hazoref st. 5, Holon 58856, Israel
Tel.: +972 3 559 3222
Fax: +972 3 559 6111
Web: www.aerotel.com
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.

About Telbios
Telbios is the Italian company leader for Telemedicine services and networks in civil and military health care structures, and for Home Care assistance, proposing services and customer oriented solutions.

Telbios features his services thanks to the assistance supplied by Telemedicine Service Center (TSC) where 24 h a day technic specialist operators and specialist phisicians are on hand for customer clinic data and diagnostic images recipt, management, archiving, monitoring and reporting. CST ensures a protect data access to information about single patient and enables the web clinic data sharing, with emergency intervention activity at every time.
For more information about Telbios, please visit Telbios website at www.telbios.com

About Aerotel Medical Systems
Aerotel Medical Systems is a world leader in cost-effective, high quality, user-friendly, medical diagnostic systems and devices for the home care, eHealth and Telemedicine markets. The company provides a complete disease management package, including transtelephonic Portable devices designed for a variety of remote diagnostic, and monitoring applications; a hardware and software platform; plus phone and web-based software.

Established in 1985, Aerotel has implemented its solutions in the USA, Europe, India, China, Australia, South America and many other countries worldwide.Frost & Sullivan has recently named Aerotel as "Company of the year" for the European telemedicine market. Aerotel products are CE marked and FDA cleared for marketing in the US with the intention to be used by patients themselves. They are designed for simple use and are famous for their quality and reliability.
For more information about Aerotel, please visit Aerotel website at www.aerotel.com

Most Popular Now

Is Your Marketing Effective for an NHS C…

How can you make sure you get the right message across to an NHS chief information officer, or chief nursing information officer? Replay this webinar with Professor Natasha Phillips, former...

Welcome Evo, Generative AI for the Genom…

Brian Hie runs the Laboratory of Evolutionary Design at Stanford, where he works at the crossroads of artificial intelligence and biology. Not long ago, Hie pondered a provocative question: If...

We could Soon Use AI to Detect Brain Tum…

A new paper in Biology Methods and Protocols, published by Oxford University Press, shows that scientists can train artificial intelligence (AI) models to distinguish brain tumors from healthy tissue. AI...

Telehealth Significantly Boosts Treatmen…

New research reveals a dramatic improvement in diagnosing and curing people living with hepatitis C in rural communities using both telemedicine and support from peers with lived experience in drug...

AI can Predict Study Results Better than…

Large language models, a type of AI that analyses text, can predict the results of proposed neuroscience studies more accurately than human experts, finds a new study led by UCL...

Research Study Shows the Cost-Effectiven…

Earlier research showed that primary care clinicians using AI-ECG tools identified more unknown cases of a weak heart pump, also called low ejection fraction, than without AI. New study findings...

Using AI to Treat Infections more Accura…

New research from the Centres for Antimicrobial Optimisation Network (CAMO-Net) at the University of Liverpool has shown that using artificial intelligence (AI) can improve how we treat urinary tract infections...

New Guidance for Ensuring AI Safety in C…

As artificial intelligence (AI) becomes more prevalent in health care, organizations and clinicians must take steps to ensure its safe implementation and use in real-world clinical settings, according to an...

Remote Telemedicine Tool Found Highly Ac…

Collecting images of suspicious-looking skin growths and sending them off-site for specialists to analyze is as accurate in identifying skin cancers as having a dermatologist examine them in person, a...

Philips Aims to Advance Cardiac MRI Tech…

Royal Philips (NYSE: PHG, AEX: PHIA) and Mayo Clinic announced a research collaboration aimed at advancing MRI for cardiac applications. Through this investigation, Philips and Mayo Clinic will look to...

New Study Reveals Why Organisations are …

The slow adoption of blockchain technology is partly driven by overhyped promises that often obscure the complex technological, organisational, and environmental challenges, according to research from the University of Surrey...

Deep Learning Model Accurately Diagnoses…

Using just one inhalation lung CT scan, a deep learning model can accurately diagnose and stage chronic obstructive pulmonary disease (COPD), according to a study published today in Radiology: Cardiothoracic...